TSBX
Turnstone Biologics
TSBX
TSBX
Delisted
TSBX was delisted on the 8th of August, 2025.
23 hedge funds and large institutions have $4.26M invested in Turnstone Biologics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-5
Holders Change %
-17.86%
% of All Funds
0.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
3
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$452K |
2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$9.83K |
3 |
NA
Nordwand Advisors
Radnor,
Pennsylvania
|
+$8.2K |
4 |
Renaissance Technologies
New York
|
+$6.68K |
5 |
HF
HRT Financial
New York
|
+$4K |
Top Sellers
1 |
Citadel Advisors
Miami,
Florida
|
-$342K |
2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$257K |
3 |
Fidelity International
Hamilton,
Bermuda
|
-$95.4K |
4 |
Barclays
London,
United Kingdom
|
-$57K |
5 |
Citigroup
New York
|
-$30.4K |